« FDA issues Warning Letters for misleading advertising of Lap-Band The | Main | FDA Approvals - China Kanghui Holdings Receives FDA Approvals for Hip and Knee »

FDA expands use of endovascular graft to treat aortic tears


FDA expands use of endovascular graft to treat aortic tears
The U.S. Food and Drug Administration today expanded the approved usage for an endovascular graft manufactured by W.L. Gore and Associates Inc. to include treatment of life-threatening tears or ruptures of the aorta (thoracic aortic transection). (MB)
 

©2006 FDA-News.com. All rights reserved.